1 Antimycobacterial Drugs Market Overview 1.1 Product Overview and Scope of Antimycobacterial Drugs 1.2 Antimycobacterial Drugs Segment by Type 1.2.1 Global Antimycobacterial Drugs Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Drugs Used for Tuberculosis 1.2.3 Drugs Used for Leprosy 1.2.4 Drugs Used for Atypical Mycobacteria 1.3 Antimycobacterial Drugs Segment by Application 1.3.1 Global Antimycobacterial Drugs Sales Comparison by Application: (2022-2028) 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Global Antimycobacterial Drugs Market Size Estimates and Forecasts 1.4.1 Global Antimycobacterial Drugs Revenue 2017-2028 1.4.2 Global Antimycobacterial Drugs Sales 2017-2028 1.4.3 Antimycobacterial Drugs Market Size by Region: 2017 Versus 2021 Versus 2028 2 Antimycobacterial Drugs Market Competition by Manufacturers 2.1 Global Antimycobacterial Drugs Sales Market Share by Manufacturers (2017-2022) 2.2 Global Antimycobacterial Drugs Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Antimycobacterial Drugs Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Antimycobacterial Drugs Manufacturing Sites, Area Served, Product Type 2.5 Antimycobacterial Drugs Market Competitive Situation and Trends 2.5.1 Antimycobacterial Drugs Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Antimycobacterial Drugs Players Market Share by Revenue 2.5.3 Global Antimycobacterial Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Antimycobacterial Drugs Retrospective Market Scenario by Region 3.1 Global Antimycobacterial Drugs Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Antimycobacterial Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Antimycobacterial Drugs Market Facts & Figures by Country 3.3.1 North America Antimycobacterial Drugs Sales by Country 3.3.2 North America Antimycobacterial Drugs Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Antimycobacterial Drugs Market Facts & Figures by Country 3.4.1 Europe Antimycobacterial Drugs Sales by Country 3.4.2 Europe Antimycobacterial Drugs Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Antimycobacterial Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Antimycobacterial Drugs Sales by Region 3.5.2 Asia Pacific Antimycobacterial Drugs Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Antimycobacterial Drugs Market Facts & Figures by Country 3.6.1 Latin America Antimycobacterial Drugs Sales by Country 3.6.2 Latin America Antimycobacterial Drugs Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Antimycobacterial Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Antimycobacterial Drugs Sales by Country 3.7.2 Middle East and Africa Antimycobacterial Drugs Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Antimycobacterial Drugs Historic Market Analysis by Type 4.1 Global Antimycobacterial Drugs Sales Market Share by Type (2017-2022) 4.2 Global Antimycobacterial Drugs Revenue Market Share by Type (2017-2022) 4.3 Global Antimycobacterial Drugs Price by Type (2017-2022) 5 Global Antimycobacterial Drugs Historic Market Analysis by Application 5.1 Global Antimycobacterial Drugs Sales Market Share by Application (2017-2022) 5.2 Global Antimycobacterial Drugs Revenue Market Share by Application (2017-2022) 5.3 Global Antimycobacterial Drugs Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Pfizer 6.1.1 Pfizer Corporation Information 6.1.2 Pfizer Description and Business Overview 6.1.3 Pfizer Antimycobacterial Drugs Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Pfizer Antimycobacterial Drugs Product Portfolio 6.1.5 Pfizer Recent Developments/Updates 6.2 Novartis 6.2.1 Novartis Corporation Information 6.2.2 Novartis Description and Business Overview 6.2.3 Novartis Antimycobacterial Drugs Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Novartis Antimycobacterial Drugs Product Portfolio 6.2.5 Novartis Recent Developments/Updates 6.3 GlaxoSmithKline 6.3.1 GlaxoSmithKline Corporation Information 6.3.2 GlaxoSmithKline Description and Business Overview 6.3.3 GlaxoSmithKline Antimycobacterial Drugs Sales, Revenue and Gross Margin (2017-2022) 6.3.4 GlaxoSmithKline Antimycobacterial Drugs Product Portfolio 6.3.5 GlaxoSmithKline Recent Developments/Updates 6.4 Bayer 6.4.1 Bayer Corporation Information 6.4.2 Bayer Description and Business Overview 6.4.3 Bayer Antimycobacterial Drugs Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Bayer Antimycobacterial Drugs Product Portfolio 6.4.5 Bayer Recent Developments/Updates 6.5 AstraZeneca 6.5.1 AstraZeneca Corporation Information 6.5.2 AstraZeneca Description and Business Overview 6.5.3 AstraZeneca Antimycobacterial Drugs Sales, Revenue and Gross Margin (2017-2022) 6.5.4 AstraZeneca Antimycobacterial Drugs Product Portfolio 6.5.5 AstraZeneca Recent Developments/Updates 6.6 Sanofi 6.6.1 Sanofi Corporation Information 6.6.2 Sanofi Description and Business Overview 6.6.3 Sanofi Antimycobacterial Drugs Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Sanofi Antimycobacterial Drugs Product Portfolio 6.6.5 Sanofi Recent Developments/Updates 6.7 Merck 6.6.1 Merck Corporation Information 6.6.2 Merck Description and Business Overview 6.6.3 Merck Antimycobacterial Drugs Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Merck Antimycobacterial Drugs Product Portfolio 6.7.5 Merck Recent Developments/Updates 6.8 Lupin 6.8.1 Lupin Corporation Information 6.8.2 Lupin Description and Business Overview 6.8.3 Lupin Antimycobacterial Drugs Sales, Revenue and Gross Margin (2017-2022) 6.8.4 Lupin Antimycobacterial Drugs Product Portfolio 6.8.5 Lupin Recent Developments/Updates 6.9 Macleods Pharmaceuticals 6.9.1 Macleods Pharmaceuticals Corporation Information 6.9.2 Macleods Pharmaceuticals Description and Business Overview 6.9.3 Macleods Pharmaceuticals Antimycobacterial Drugs Sales, Revenue and Gross Margin (2017-2022) 6.9.4 Macleods Pharmaceuticals Antimycobacterial Drugs Product Portfolio 6.9.5 Macleods Pharmaceuticals Recent Developments/Updates 6.10 Systopic Laboratories 6.10.1 Systopic Laboratories Corporation Information 6.10.2 Systopic Laboratories Description and Business Overview 6.10.3 Systopic Laboratories Antimycobacterial Drugs Sales, Revenue and Gross Margin (2017-2022) 6.10.4 Systopic Laboratories Antimycobacterial Drugs Product Portfolio 6.10.5 Systopic Laboratories Recent Developments/Updates 6.11 Zydus Cadila 6.11.1 Zydus Cadila Corporation Information 6.11.2 Zydus Cadila Antimycobacterial Drugs Description and Business Overview 6.11.3 Zydus Cadila Antimycobacterial Drugs Sales, Revenue and Gross Margin (2017-2022) 6.11.4 Zydus Cadila Antimycobacterial Drugs Product Portfolio 6.11.5 Zydus Cadila Recent Developments/Updates 7 Antimycobacterial Drugs Manufacturing Cost Analysis 7.1 Antimycobacterial Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Antimycobacterial Drugs 7.4 Antimycobacterial Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Antimycobacterial Drugs Distributors List 8.3 Antimycobacterial Drugs Customers 9 Antimycobacterial Drugs Market Dynamics 9.1 Antimycobacterial Drugs Industry Trends 9.2 Antimycobacterial Drugs Market Drivers 9.3 Antimycobacterial Drugs Market Challenges 9.4 Antimycobacterial Drugs Market Restraints 10 Global Market Forecast 10.1 Antimycobacterial Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Antimycobacterial Drugs by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Antimycobacterial Drugs by Type (2023-2028) 10.2 Antimycobacterial Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Antimycobacterial Drugs by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Antimycobacterial Drugs by Application (2023-2028) 10.3 Antimycobacterial Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Antimycobacterial Drugs by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Antimycobacterial Drugs by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Antimycobacterial Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Antimycobacterial Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global Antimycobacterial Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Antimycobacterial Drugs Market Competitive Situation by Manufacturers in 2021 Table 5. Global Antimycobacterial Drugs Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Antimycobacterial Drugs Sales Market Share by Manufacturers (2017-2022) Table 7. Global Antimycobacterial Drugs Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Antimycobacterial Drugs Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Antimycobacterial Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Antimycobacterial Drugs Manufacturing Sites and Area Served Table 11. Manufacturers Antimycobacterial Drugs Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Antimycobacterial Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antimycobacterial Drugs as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Antimycobacterial Drugs Sales by Region (2017-2022) & (K Units) Table 16. Global Antimycobacterial Drugs Sales Market Share by Region (2017-2022) Table 17. Global Antimycobacterial Drugs Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Antimycobacterial Drugs Revenue Market Share by Region (2017-2022) Table 19. North America Antimycobacterial Drugs Sales by Country (2017-2022) & (K Units) Table 20. North America Antimycobacterial Drugs Sales Market Share by Country (2017-2022) Table 21. North America Antimycobacterial Drugs Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Antimycobacterial Drugs Revenue Market Share by Country (2017-2022) Table 23. Europe Antimycobacterial Drugs Sales by Country (2017-2022) & (K Units) Table 24. Europe Antimycobacterial Drugs Sales Market Share by Country (2017-2022) Table 25. Europe Antimycobacterial Drugs Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Antimycobacterial Drugs Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Antimycobacterial Drugs Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Antimycobacterial Drugs Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Antimycobacterial Drugs Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Antimycobacterial Drugs Revenue Market Share by Region (2017-2022) Table 31. Latin America Antimycobacterial Drugs Sales by Country (2017-2022) & (K Units) Table 32. Latin America Antimycobacterial Drugs Sales Market Share by Country (2017-2022) Table 33. Latin America Antimycobacterial Drugs Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Antimycobacterial Drugs Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Antimycobacterial Drugs Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Antimycobacterial Drugs Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Antimycobacterial Drugs Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Antimycobacterial Drugs Revenue Market Share by Country (2017-2022) Table 39. Global Antimycobacterial Drugs Sales by Type (2017-2022) & (K Units) Table 40. Global Antimycobacterial Drugs Sales Market Share by Type (2017-2022) Table 41. Global Antimycobacterial Drugs Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Antimycobacterial Drugs Revenue Share by Type (2017-2022) Table 43. Global Antimycobacterial Drugs Price by Type (2017-2022) & (USD/Unit) Table 44. Global Antimycobacterial Drugs Sales (K Units) by Application (2017-2022) Table 45. Global Antimycobacterial Drugs Sales Market Share by Application (2017-2022) Table 46. Global Antimycobacterial Drugs Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Antimycobacterial Drugs Revenue Share by Application (2017-2022) Table 48. Global Antimycobacterial Drugs Price by Application (2017-2022) & (USD/Unit) Table 49. Pfizer Corporation Information Table 50. Pfizer Description and Business Overview Table 51. Pfizer Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 52. Pfizer Antimycobacterial Drugs Product Table 53. Pfizer Recent Developments/Updates Table 54. Novartis Corporation Information Table 55. Novartis Description and Business Overview Table 56. Novartis Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 57. Novartis Antimycobacterial Drugs Product Table 58. Novartis Recent Developments/Updates Table 59. GlaxoSmithKline Corporation Information Table 60. GlaxoSmithKline Description and Business Overview Table 61. GlaxoSmithKline Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 62. GlaxoSmithKline Antimycobacterial Drugs Product Table 63. GlaxoSmithKline Recent Developments/Updates Table 64. Bayer Corporation Information Table 65. Bayer Description and Business Overview Table 66. Bayer Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 67. Bayer Antimycobacterial Drugs Product Table 68. Bayer Recent Developments/Updates Table 69. AstraZeneca Corporation Information Table 70. AstraZeneca Description and Business Overview Table 71. AstraZeneca Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 72. AstraZeneca Antimycobacterial Drugs Product Table 73. AstraZeneca Recent Developments/Updates Table 74. Sanofi Corporation Information Table 75. Sanofi Description and Business Overview Table 76. Sanofi Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 77. Sanofi Antimycobacterial Drugs Product Table 78. Sanofi Recent Developments/Updates Table 79. Merck Corporation Information Table 80. Merck Description and Business Overview Table 81. Merck Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 82. Merck Antimycobacterial Drugs Product Table 83. Merck Recent Developments/Updates Table 84. Lupin Corporation Information Table 85. Lupin Description and Business Overview Table 86. Lupin Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 87. Lupin Antimycobacterial Drugs Product Table 88. Lupin Recent Developments/Updates Table 89. Macleods Pharmaceuticals Corporation Information Table 90. Macleods Pharmaceuticals Description and Business Overview Table 91. Macleods Pharmaceuticals Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 92. Macleods Pharmaceuticals Antimycobacterial Drugs Product Table 93. Macleods Pharmaceuticals Recent Developments/Updates Table 94. Systopic Laboratories Corporation Information Table 95. Systopic Laboratories Description and Business Overview Table 96. Systopic Laboratories Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 97. Systopic Laboratories Antimycobacterial Drugs Product Table 98. Systopic Laboratories Recent Developments/Updates Table 99. Zydus Cadila Corporation Information Table 100. Zydus Cadila Description and Business Overview Table 101. Zydus Cadila Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 102. Zydus Cadila Antimycobacterial Drugs Product Table 103. Zydus Cadila Recent Developments/Updates Table 104. Production Base and Market Concentration Rate of Raw Material Table 105. Key Suppliers of Raw Materials Table 106. Antimycobacterial Drugs Distributors List Table 107. Antimycobacterial Drugs Customers List Table 108. Antimycobacterial Drugs Market Trends Table 109. Antimycobacterial Drugs Market Drivers Table 110. Antimycobacterial Drugs Market Challenges Table 111. Antimycobacterial Drugs Market Restraints Table 112. Global Antimycobacterial Drugs Sales Forecast by Type (2023-2028) & (K Units) Table 113. Global Antimycobacterial Drugs Sales Market Share Forecast by Type (2023-2028) Table 114. Global Antimycobacterial Drugs Revenue Forecast by Type (2023-2028) & (US$ Million) Table 115. Global Antimycobacterial Drugs Revenue Market Share Forecast by Type (2023-2028) Table 116. Global Antimycobacterial Drugs Sales Forecast by Application (2023-2028) & (K Units) Table 117. Global Antimycobacterial Drugs Sales Market Share Forecast by Application (2023-2028) Table 118. Global Antimycobacterial Drugs Revenue Forecast by Application (2023-2028) & (US$ Million) Table 119. Global Antimycobacterial Drugs Revenue Market Share Forecast by Application (2023-2028) Table 120. Global Antimycobacterial Drugs Sales Forecast by Region (2023-2028) & (K Units) Table 121. Global Antimycobacterial Drugs Sales Market Share Forecast by Region (2023-2028) Table 122. Global Antimycobacterial Drugs Revenue Forecast by Region (2023-2028) & (US$ Million) Table 123. Global Antimycobacterial Drugs Revenue Market Share Forecast by Region (2023-2028) Table 124. Research Programs/Design for This Report Table 125. Key Data Information from Secondary Sources Table 126. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Antimycobacterial Drugs Figure 2. Global Antimycobacterial Drugs Market Share by Type in 2021 & 2028 Figure 3. Drugs Used for Tuberculosis Product Picture Figure 4. Drugs Used for Leprosy Product Picture Figure 5. Drugs Used for Atypical Mycobacteria Product Picture Figure 6. Global Antimycobacterial Drugs Market Share by Application in 2021 & 2028 Figure 7. Hospital Pharmacies Figure 8. Retail Pharmacies Figure 9. Online Pharmacies Figure 10. Global Antimycobacterial Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Antimycobacterial Drugs Market Size (2017-2028) & (US$ Million) Figure 12. Global Antimycobacterial Drugs Sales (2017-2028) & (K Units) Figure 13. Antimycobacterial Drugs Sales Share by Manufacturers in 2021 Figure 14. Global Antimycobacterial Drugs Revenue Share by Manufacturers in 2021 Figure 15. The Global 5 and 10 Largest Antimycobacterial Drugs Players: Market Share by Revenue in 2021 Figure 16. Antimycobacterial Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 17. Global Antimycobacterial Drugs Sales Market Share by Region (2017-2022) Figure 18. Global Antimycobacterial Drugs Sales Market Share by Region in 2021 Figure 19. Global Antimycobacterial Drugs Revenue Market Share by Region (2017-2022) Figure 20. Global Antimycobacterial Drugs Revenue Market Share by Region in 2021 Figure 21. U.S. Antimycobacterial Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. Canada Antimycobacterial Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. Germany Antimycobacterial Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. France Antimycobacterial Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. U.K. Antimycobacterial Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Italy Antimycobacterial Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. Russia Antimycobacterial Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. China Antimycobacterial Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. Japan Antimycobacterial Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. South Korea Antimycobacterial Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. India Antimycobacterial Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. Australia Antimycobacterial Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Taiwan Antimycobacterial Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Indonesia Antimycobacterial Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Thailand Antimycobacterial Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Malaysia Antimycobacterial Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Philippines Antimycobacterial Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Vietnam Antimycobacterial Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Mexico Antimycobacterial Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Brazil Antimycobacterial Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Argentina Antimycobacterial Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Turkey Antimycobacterial Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Saudi Arabia Antimycobacterial Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. UAE Antimycobacterial Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. Sales Market Share of Antimycobacterial Drugs by Type (2017-2022) Figure 46. Manufacturing Cost Structure of Antimycobacterial Drugs Figure 47. Manufacturing Process Analysis of Antimycobacterial Drugs Figure 48. Antimycobacterial Drugs Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Pfizer Novartis GlaxoSmithKline Bayer AstraZeneca Sanofi Merck Lupin Macleods Pharmaceuticals Systopic Laboratories Zydus Cadila